A Percutaneous Ultrasound Device With Needle Guide for Vascular Access

Status Not yet recruiting

Clinical Trial Summary

This first-in-human pilot study seeks to evaluate the feasibility and safety of using a percutaneous ultrasound device with needle guide for vascular access. Eligible participants will undergo the procedure of transcatheter arterial chemoembolization for primary or metastatic liver cancer, as part of participants' clinical care. The percutaneous ultrasound device with needle guide will be deployed in eligible participants at the beginning of the procedure for guiding a needle inside the femoral artery. Once the needle is inside the artery, then a guide wire is advanced inside the needle and vascular access is successfully obtained. The study will identify whether this ultrasound-based device with needle guide is helpful for guiding a needle inside the femoral artery.

Clinical Trial Description

This NIH Small Business Innovation Research (SBIR)-funded study seeks to test a forward-viewing, ultrasound (US)-based device with needle guide for vascular access. Access to large arteries is an indispensable step of any trans-arterial catheterization procedure. Surface US-guided vascular cannulation greatly improves first-pass success and reduces complications and is recommended as the preferred technique by numerous specialties and governmental agencies. Surface US-guided cannulation has several key limitations, including dependence on operator skills and experience. Safety and success of vascular access could be vastly improved with a single integrated imaging/interventional device with a small footprint that enables a single-hand operation of the US probe and visualizes the operating needle in real-time. Reliable and accurate real-time image guidance for vascular access has the potential to appreciably impact public health by enhancing patient safety and convenience, improving procedural accuracy and increasing procedure throughput. Successful implementation has the potential to reduce care and complication costs across millions of vascular access procedures. Vu-Path™ is a small footprint, US-based device with needle guide. It is a dual-lumen instrument with parallel US imaging and interventional lumens. The forward-viewing US transducer is located at the catheter tip and focused such that the tip of the needle in the interventional lumen, and all proximate structures, are always clearly visualized in real time throughout the procedure. This is a first-in-human pilot study of the Vu-Path™ device, aiming to its establish clinical feasibility and safety for exemplary use. ;

Study Design

Related Conditions & MeSH terms

Vascular Access

Clinical Trial Details

NCT number	NCT03879161
Study type	Interventional
Source	Johns Hopkins University
Contact	Robert Liddell, MD
Phone	410-614-5183
Email	rliddel1@jhmi.edu
Status	Not yet recruiting
Phase	N/A
Start date	September 2024
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03183245` - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis	Phase 3
Completed	`NCT01453322` - Video Documentation of Localized Complications	N/A
Completed	`NCT05119673` - POCUS for Difficult Peripheral Access in the Emergency Department - a RCT	N/A
Completed	`NCT00892671` - Airway Management and Vascular Access Simulation	N/A
Completed	`NCT04135417` - Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis	Phase 2
Completed	`NCT02644941` - Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis	Phase 3
Completed	`NCT01638065` - A Comprehensive Look at Vascular Access	N/A
Completed	`NCT00222430` - Fluoroscopy Guided Femoral Arterial Access	N/A
Recruiting	`NCT05733637` - HRAD-Vascular Access
Completed	`NCT02112669` - A Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Arteriovenous Fistulas	N/A
Completed	`NCT04135547` - Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest	N/A
Recruiting	`NCT03427723` - Accuvein Versus Standard Care for Intravenous Cannulation Procedure in Children	N/A
Completed	`NCT02125565` - Radial ABG Sampling: A RCT of Lidocaine Local Anaesthesia	N/A
Not yet recruiting	`NCT05118581` - Safety and Efficacy of Ultrasound Guided Vascular Access	N/A
Completed	`NCT04821362` - Comparison of Different Techniques on First Attempt Success in Difficult Vascular Access Patients	N/A
Completed	`NCT04695054` - Buzzy Plus EMLA Cream for Vascular Access in Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.